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Glial cells are thought to supply energy for neurotransmission by increasing nonoxidative glycolysis; however, oxidative metabolism in
gliamayalso contribute to increasedbrain activity. To study glial contribution to cerebral energymetabolism in theunanesthetized state,
we measured neuronal and glial metabolic fluxes in the awake rat brain by using a double isotopic-labeling technique and a two-
compartment mathematical model of neurotransmitter metabolism. Rats (n 23) were infused simultaneously with 14C-bicarbonate
and [1-13C]glucose for up to 1 hr. The 14C and 13C labeling of glutamate, glutamine, and aspartate was measured at five time points in
tissue extracts using scintillation counting and 13C nuclear magnetic resonance of the chromatographically separated amino acids. The
isotopic 13C enrichment of glutamate and glutamine was different, suggesting significant rates of glial metabolism compared with the
glutamate–glutamine cycle. Modeling the 13C-labeling time courses alone and with 14C confirmed significant glial TCA cycle activity
(VPDH
(g) ,0.5 mol  gm1  min1) relative to the glutamate–glutamine cycle (VNT) (0.5–0.6 mol  gm
1  min1). The glial TCA
cycle rate was30% of total TCA cycle activity. A high pyruvate carboxylase rate (VPC ,0.14–0.18mol  gm
1  min1) contributed
to the glial TCA cycle flux. This anaplerotic rate in the awake rat brain was severalfold higher than under deep pentobarbital anesthesia,
measured previously in our laboratory using the same 13C-labeling technique. We postulate that the high rate of anaplerosis in awake
brain is linked to brain activity by maintaining glial glutamine concentrations during increased neurotransmission.
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Introduction
Cerebral energy metabolism is compartmentalized between glia
and neurons. The main excitatory neurotransmitter, glutamate
(Glu), is localized primarily in neurons (Chapa et al., 2000),
whereasmost of glutamine (Gln) is in astroglia (Storm-Mathisen
et al., 1992). Furthermore, glutamine synthetase (EC 6.3.1.2) and
the anaplerotic enzyme pyruvate carboxylase (EC 6.4.1.1) are
present almost exclusively in glial cells (Martinez-Hernandez et
al., 1977; Shank et al., 1985). Astrocytes take up almost all of the
glutamate released from neighboring neurons during neuro-
transmission (Bergles et al., 1999) and convert it into electro-
physiologically inactive glutamine.Glutamine released by astrocytes
then replenishes the presynaptic glutamate neurotransmitter pools
by the so-called “glutamate–glutamine cycle.”
Glial cells contribute to brain energy metabolism by the sig-
nificant glial TCA cycle rates and pyruvate carboxylase activity
measured in both animals and humans (Lapidot and Gopher,
1994; Gruetter et al., 1998, 2001; Sibson et al., 2001; Bluml et al.,
2002; Choi et al., 2002; Lebon et al., 2002). However, some re-
ports suggested that the astroglial contribution to neurotrans-
mission is limited to nonoxidative glycolysis (Shulman et al.,
2003). According to theMagistretti hypothesis (Magistretti et al.,
1999), ATP produced by glycolysis in astrocytes powers glu-
tamate–glutamine cycling (reestablishment of the Na–K
gradient and conversion of glutamate to glutamine) during acti-
vation, whereas the resulting lactate is oxidized in neurons (Pel-
lerin and Magistretti, 1994). Although this proposal recognized
astrocytes as an integral part of brain function, it also led to the
suggestion that neuronal metabolism is primarily oxidative and
glial metabolism is exclusively glycolytic (Sibson et al., 1998;
Shulman et al., 2003), which is controversial (Dienel and Hertz,
2001; Gjedde and Marrett, 2001; Gruetter et al., 2001).
Whether glial oxidative metabolism increases with increased
brain activity is not known. Sodium-dependent glutamate up-
take, a condition paralleling glutamate neurotransmission, acti-
vates oxidative metabolism in astrocyte cultures (Eriksson et al.,
1995). Furthermore, oxidative metabolism of glucose in astro-
cytes supplies a considerable portion of the energy required for
glutamine synthesis in the rat brain (Garcia-Espinosa et al.,
2003). We therefore hypothesized that glial oxidative ATP pro-
duction increases with neurotransmission.
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Our aim was to assess glial and neuronal contributions to
cerebral energy metabolism in the awake rat brain and compare
themwith those under deep pentobarbital anesthesia (Choi et al.,
2002). We simultaneously infused tracer H14CO3
 and
[1-13C]glucose into awake rats andmeasured the time courses of
14C and 13C labeling of Glu, Gln, and aspartate (Asp) in whole
brain extracts. Brain glutamine synthesis, which is a glial process,
and labeling of glutamate from 13C-glucose, which reflects
mainly neuronal metabolism, can be followed simultaneously by
13C nuclear magnetic resonance (NMR) spectroscopy. In con-
trast, 14C-bicarbonate enters the TCA cycle via pyruvate carbox-
ylase only in glial cells and therefore can validate the anaplerotic
activity determined by 13C NMR. To extend our previous 14C
and 13C steady-state kinetic analyses (Xu et al., 2004), we fitted a
two-compartmentmathematical model of neurotransmitterme-
tabolism (Gruetter et al., 2001) to the 13C time courses of Glu,
Gln, and Asp alone and in combination with the 14C time
courses.
Materials andMethods
Animal and sample preparation. The preparation and perfusions of the
animals followed procedures described previously (Xu et al., 2004). The
study protocol was approved by the Institutional Review Committee of
the Wake Forest University School of Medicine. Animals were treated in
accordance with the guidelines published in the National Institutes of
Health Guide for the Care and Use of Laboratory Animals. Briefly, after
sterile surgery, whereby catheters were implanted in the carotid artery
and jugular vein, male Sprague Dawley rats (n 23; 247 12 gm) were
allowed to recover with ad libitum access to food and water for 48–72 hr.
On the day of the experiment, they were infused through the jugular vein
with a solution containing 1 mCi/ml H14CO3
 and 1 M [1-13C]glucose
(99% enriched) in buffered saline. A bolus of 0.5 ml of this solution was
followed by a steady-state infusion of 1 ml/hr. Blood samples were col-
lected from the carotid artery to determine acid volatile ( 14CO2) radio-
activity and glucose isotopic enrichments. Tissue extraction, rather than
in vivo measurements, was chosen for metabolic rate determinations to
permit the dual isotope experiment. In addition, extraction permitted
the study of awake animals. In vivo studies of awake animals would
require immobilization andwould be difficult to performwithout duress
to the animal. After decapitation, the heads were frozen quickly in liquid
nitrogen at 5, 10, 20, 40, and 60min after the start of infusion (three to six
rats per time point). Whole brains, excluding the cerebellum, were ex-
tracted with perchloric acid, and metabolites were separated chromato-
graphically as described previously (Lieth et al., 2001; Xu et al., 2004) to
analyze 14C labeling by scintillation counting and 13C labeling by NMR.
Before analysis, the glutamine samples were converted by glutaminase to
glutamate because of its higher stability.
Chemicals. 14C sodium bicarbonate (NEC-086H)was purchased from
PerkinElmer Life Sciences (Boston, MA). D-Glucose (1- 13C; CLM-420)
was purchased from Cambridge Isotope Laboratories (Andover, MA).
Enzymes formetabolic analyses were purchased from Sigma-Aldrich (St.
Louis, MO) or Roche Diagnostics (Indianapolis, IN).
Determination of 14C-specific activities by scintillation counting. The
specific activity of serum H14CO3
 was constant with time in individual
rats; therefore, the time-averaged serum H14CO3
-specific radioactivity
in each animal was used to calculate the nanomoles of H14CO3
 incor-
porated into the brain metabolites. The fraction of the metabolite pool
that originated from the infused bicarbonate was then determined based
on total metabolite concentrations measured using enzymatic methods
(Lieth et al., 2001).
Determination of 13C isotopic enrichments by NMR spectroscopy. Puri-
fied metabolites (Glu, Asp, and Gln after conversion to Glu) were lyoph-
ilized and resuspended in phosphate buffer (25 mM) containing 10%
D2O, 11.5mM99%enriched
13C-formate (internal standard), and 0.02%
(w/v) sodium azide, pH 7.1. Their 13CNMR spectra were acquired using
a 600MHzVarian (Palo Alto, CA)UNITY INOVA spectrometer at 25°C.
A pulse-acquire sequence was used under fully relaxed conditions [45°
pulse, calibrated in each sample; repetition time (TR), 4.6 sec, 2 T1 of
the measured carbon with the longest T1, namely C2 of Asp]. Number of
transients (nt) ranged from 800 to 3200. WALTZ-16 (Shaka et al., 1983)
was used for nuclear Overhauser effect (NOE) generation during the
relaxation delay and for decoupling during acquisition. The decoupler
field was calibrated on eachmeasurement day, and the NOE factors were
determined using high-concentration samples, as well as aqueous solu-
tions of commercial material. Reference formate spectra were acquired
immediately before each metabolite spectrum in the same manner (45°
pulse, TR, 36.5 sec, 2 T1 of formate; nt 8).
The concentration of the 13C-labeled metabolites was determined
based on the reference formate signal by measuring peak areas using
deconvolution software provided with the spectrometer and by correct-
ing the resulting area for the measured NOEs. The isotopic enrichments
were then determined based on concurrently measured total metabolite
concentrations using enzymatic methods (Lieth et al., 2001). The isoto-
pic enrichments of the 60 min samples were also determined by isoto-
pomer analysis as described by Choi et al. (2002), whereby the enrich-
ments are obtained from peak area ratios in a single experiment.
Therefore, the isotopomer analysis results were considered more accu-
rate than those obtained by NMR combined with enzyme assays, and the
data at the remaining time points were scaled accordingly. The scaling
factors ranged from 0.9 to 1.1.
To determine the precision of the isotopic enrichment measurements
by NMR, a low-concentration Asp sample [signal-to-noise ratio (S/N),
12] and a high-concentration Glu sample (S/N,100) were measured
on 4 different days. The coefficients of variation in isotopic enrichments
were as follows: Asp C2, 3.4%, Asp C3, 9%, Glu C2, 3.6%, Glu C3, 2.1%,
and Glu C4, 1.1%, indicating high reproducibility of the NMR method.
Therefore, the error in the measurements was dominated by animal-to-
animal variation rather than the intrinsic sensitivity of the NMR
measurements.
The isotopic enrichments of the serum glucose samples were obtained
by 1HNMR spectroscopy. A proton bound to an unlabeled C1 carbon in
-glucose gives rise to a singlet at 5.24 ppm, whereas a proton bound to
a labeledC1 carbon results in a doublet at the same chemical shift. There-
fore, the ratio of the integral of this doublet to the total H1 integral
provides the isotopic enrichment for glucose C1. For this measurement,
the deproteinized serum glucose samples were lyophilized and resus-
pended in phosphate buffer (25 mM) in 100% D2O containing 0.02%
sodium azide, pH 7.1. The spectra were acquired at 600 MHz with a
pulse-acquire sequence at 37°C. A TR (22 sec) of greater than 5 T1 of
the 12C-bound protons was used in combination with a 90° excitation
pulse (nt  32). The T1 relaxation times of the
12C- and 13C-bound
protons were determined using an inversion recovery sequence. The
average isotopic enrichment of [1- 13C]glucose in blood was 55%. The
isotopic enrichment of brain glucose was calculated based on the blood
values assuming reversible Michaelis–Menten kinetics (Choi et al.,
2001). No C6 labeling of glucose was observed in 13C spectra, indicating
negligible effects of hepatic gluconeogenesis to labeling during the
experiments.
Metabolic modeling. A previously described mathematical model of
glucose and neurotransmitter metabolism (Gruetter et al., 2001) was
fitted to the 13C-labeling time courses of Glu and Gln C4, C3, and C2, as
well as an average of Asp C2 and C3 using the software SAAM II (The
SAAM Institute, Seattle, WA). To minimize the impact of potential out-
liers,median values were used for each time point. In addition, themodel
was amended to fit the 14C-labeling time courses of Glu C1 and Gln C1
simultaneously with the 13C time courses, as well as to predict these time
courses from 13C data alone.
The modeling assumed metabolic steady state, which posits that (1)
total metabolite pools do not change during the experiment (this was
confirmed by enzymatic determinations), and (2) fluxes do not change
during the experiment. The previous model was expanded to include a
label dilution flux (Vex) in the glial compartment at the level of glutamine
(Fig. 1), which was found to be equivalent to label dilution at the entry
into the glial TCA cycle. Label dilution at the level of acetyl-CoA is pos-
sible, for example, as a result of fatty acid oxidation in glia (Ebert et al.,
2003). The 13C enrichment of acetyl-CoA C2 when calculated from the
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enrichment of Glu (Malloy et al., 1990) was almost one-half of the iso-
topic enrichment of glucose but was somewhat less when calculated from
the enrichment of Gln, indicating some dilution of the glial pools.
Backflux from oxaloacetate to symmetric fumarate results in label
scrambling between the C1 and C4, as well as C2 and C3, positions of
oxaloacetate. The 14C label scrambled into the C1 of oxaloacetate is lost
subsequently to CO2 at the level of isocitrate dehydrogenase, thereby
reducing the specific activity in the amino acids by atmost 50% (Xu et al.,
2004). The model was extended to allow for oxaloacetate–fumarate cy-
cling, which appears incomplete in astrocyte cultures (Merle et al., 1996),
as well as in human and animal brain, as judged from the unequal label-
ing of Gln C2 and C3 (Lapidot and Gopher, 1994; Gruetter et al., 1998,
2001).
The total oxidative glucose consumption (CMRglc(ox)) was defined as
the rate of glucose equivalents entering the TCA cycle, as follows:
CMRglc(ox) VPC
VPDH Vg
2
. (1)
The rate of glial ATP synthesis was calculated assuming a P:0 ratio of 2.5:1
and taking into account small H losses that occur while transporting
reducing equivalents from the cytosol to the mitochondrion, as follows:
VATP
(g)  1 x CMRglc(ox) 9.5 VPC 14.5 Vg , (2)
and likewise for the neuronal compartment, as follows:
VATP
(n)  x CMRglc(ox) 14.5 VPDH , (3)
where VPDH, Vg, and VPC are expressed in micromoles of pyruvate per
gram per minute.
These calculations assumed that a fraction (x) of glucose phosphory-
lation occurs in the neuronal compartment.
Total metabolite pools used in modeling were measured in extracts as
nanomoles per milligram of protein and converted to micromoles per
gram based on an average protein content of 0.075 mg of protein per
milligram of wet weight, as measured by the Bradford procedure (Brad-
ford, 1976). The resulting metabolite concentrations were 10.5  0.5
mol/gm for Glu, 4.2 0.5 mol/gm for Gln, and 2.7 0.2 mol/gm
forAsp (mean SD). The glialGlu poolwas assumed to be 0.9mol/gm,
and the neuronal Gln pool was assumed to be 0.3 mol/gm. Although
somemetabolic flux estimates depended slightly on the assumed glial Glu
fraction (Gruetter et al., 2001), the conclusions of the present study were
not affected when changing the glial Glu fraction from 2 to 15%.
Results
Insights into compartmentation from 14C incorporation into
amino acids
14C-labeled bicarbonate first labels glial oxaloacetate, which ex-
changes with glial Asp via transport across the mitochondrial
membrane and transamination (Xu et al., 2004). The 14C labeling
of Asp reached steady state at 5 min, consistent with rapid turn-
over of a small glial Asp pool relative to the metabolic reactions.
Furthermore, the specific activity of Asp was much lower than
Gln, indicating that themajority of Asp is not localized to the glial
compartment.
The 14C-specific activity of Gln was higher than that of Glu
(relative to the pool size), reaffirming the predominantly glial
localization ofCO2 fixation and thus pyruvate carboxylation. The
extent of labeling of Gln and Glu was significant (15  1.6% of
Gln and 6.7  0.5% of Glu was derived from fixed 14CO2 at 60
min; mean  SEM), indicating substantial rates of anaplerosis
relative to the glutamate–glutamine cycle rate.
Insights into compartmentation from 13C incorporation into
amino acids
The 13C enrichment of Gln was lower than Glu in all positions
(Fig. 2, Table 1), indicating a label dilution flux specific to the glial
compartment. The C2 of Gln was more highly enriched than C3
at all time points ( p	 0.05) (Fig. 3), and the C2 of Glu was more
highly enriched thanC3 ( p	 0.05) at all time points except at t
10 min. On average, the difference in labeling of C2 and C3 was
higher in Gln than Glu, but this reached statistical significance
only for the earlier time points ( p	 0.05). In contrast, the label-
ing of Asp C2 was identical to C3 within the experimental error
(Fig. 2, Table 1), consistent with most Asp being in the neuronal
Figure 1. A, Scheme depicting the flow of label (shaded circle) after administration of tracer
H 14CO3
.B, Schemedepicting the flowof label after administration of [1-13C]glucose (modified
from Gruetter et al., 2001). In this scheme, the filled circles represent carbon atoms labeled in
the first turn of the TCA cycle, and the shaded circles represent carbon atoms labeled in the
second turn. The labeling patterns of oxaloacetate (OAA) and 2-oxoglutarate (2-OG) after the
entry of label into the TCA cycle via pyruvate dehydrogenase (PDH) or pyruvate carboxylase (PC)
activity are shown. The locations of the labels are shown as subscripts; for example, Asp2,3
designates labels on C2 and C3 positions of aspartate. The superscripts designate glial (g) and
neuronal (n) pools of amino acids, with the larger pools shown in bold. Pyr, Pyruvate; Lac,
lactate; V PDH
(g) , glial pyruvate dehydrogenase rate; VNT
app, glutamate–glutamine cycle rate; Vx ,
exchange rate between cytosolic amino acids andmitochondrial TCA cycle intermediates;Vfum ,
fumarase rate (backflux from OAA to fumarate); Vefflux , rate of Gln loss from the glial compart-
ment; Vsyn , rate of glutamine synthetase; Vex , rate of label dilution of Gln; Vout , rate of label
dilution of lactate.
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compartment. Neuronal Asp in turn is the
label precursor for the C2 and C3 in Glu,
and Glu labeling was not the same in C2
and C3. Therefore, the combined action of
label exchange between cytosolic amino
acids and mitochondrial TCA cycle inter-
mediates,Vx, andneuronal TCAcycle flux,
VPDH, was not overwhelmingly faster than
the rate of the glutamate–glutamine cycle
(Fig. 1B). However, the distinctly different
labeling of Glu compared with Gln, with
Gln having a greater difference between
the enrichments of C2 and C3 than Glu,
indicates that glial reactions such as the
pyruvate carboxylase activity were also
substantial compared with the rate of the
glutamate–glutamine cycle.
Metabolic modeling of
compartmentalized
neurotransmitter metabolism
To obtain metabolic fluxes, we fitted the
metabolic model described previously
(Gruetter et al., 1998, 2001) to the 13C
data. As stated above, the labeling of Gln
from [1-13C]glucose was less than that of
Glu, consistent with previous studies
(Lapidot and Gopher, 1994; Aureli et al.,
1997; Shen et al., 1999; Choi et al., 2002;
Merle et al., 2002). Because glucose first
labels Glu, Gln labeling could be delayed
because of a low glutamate–glutamine cy-
cle rate. Indeed, VNT was 0.17  0.11
mol  gm1  min1 when assuming
equal steady-state labeling of Glu and Gln;
however, the 13C modeling predicted only
the time course of 14C-glutamate but not
that of 14C-glutamine. Furthermore, addi-
tion of the 14C data increased VNT to
0.44 0.11 mol  gm1  min1. There-
fore, the lower 13C enrichment in Gln was
explained by dilution in the glial cells and a
dilution term, Vex, in the glial compart-
ment was added to the model (Fig. 1).
Significant pyruvate carboxylase (VPC)
and glial TCA cycle (Vg) fluxes were mea-
sured (Table 2, top row). Glial ATP synthesis (Eq. 2) was50%
of that in the neuronal compartment, indicating that glial metab-
olism is substantial in the awake rat brain. The rate of the gluta-
mate–glutamine cycle was also high but still substantially lower
than total glucose oxidation (VNT/CMRglc(ox)  0.62  0.24).
Label exchange between mitochondrial TCA cycle intermediates
and cytosolic amino acids, Vx (Fig. 1), was statistically not differ-
ent from the neuronal TCA cycle rate VPDH.
The simultaneous administration of H14CO3
 and
[1-13C]glucose allowed the comparison of metabolic fluxes ob-
tained from the 13C NMR data with the time courses of 14C
labeling. Themetabolic rates weremostly unaffectedwhether 14C
time courses were fitted simultaneously or not, except for a slight
increase in VPC after inclusion of the
14C data (Fig. 3; Table 2,
bottom row).When themodel allowed for backflux fromoxaloa-
cetate to fumarate (Vfum), fitting the
13C data alone produced
identical pyruvate carboxylase rates to fitting both 13C and 14C
data (Table 3). Furthermore, the prediction of Glu and Gln 14C
time courses by the 13C modeling alone improved considerably
after the inclusion of Vfum (Fig. 4). Interestingly, the total oxida-
tive glucose consumption did not change after fitting the 14C and
13C data together and was mostly independent of modeling as-
sumptions, such as the inclusion of Vex and fumarase backflux
(scrambling label from oxaloacetate to fumarate) in the model
(Tables 2, 3). This was consistent with our previous findings
(Gruetter et al., 2001) and indicated that, with the use of a two-
Figure 2. Representative 13C NMR spectra of Glu, Gln, and Asp from one rat brain extracted at 60 min after start of
[1-13C]glucose infusion. Observable isotopomers are shown. For example, the doublet at the C2 position of Glu that arises as a
result of coupling to a labeled C3 is designated as C2,3. Spectra are line broadenedby1.2Hz. Thenumbers in theboxes indicate the
isotopic enrichment (percentage) of the particular carbon nucleus in this brain. Although the intensity of Asp C3 is higher thanAsp
C2, therewas no difference in their peak areas, and the difference in intensities was attributable to the smaller linewidth–higher
mobility of C3.
Table 1. Average SD isotopic 13C enrichments (%)
C2 C3 C4
Glu 19.2 3.6*,** 15.9 2.8** 25.8 4.5**
Gln 14.9 3.0* 12.0 2.2 21.0 4.0
Asp 23.5 7.6 23.4 7.8
Values are averages of 40 and 60 min data (n 7 rat brains).
*p	 0.001 between C2 and C3 (paired two-tailed t test); **p	 0.02 between Glu and Gln.
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compartment model, the CMRglc(ox) was a robustly determined
parameter.
Discussion
Here, we demonstrate that glial cells produce approximately one-
third of total ATP in the awake rat brain. At least two-thirds of the
glial ATP production are oxidative, and the anaplerotic rate is
severalfold higher than in the deeply anesthetized rat brain (Choi
et al., 2002).
Evaluation of the metabolic model
The current study provides evidence for a dilution flux (Vex) in
glia. This dilution is plausible because astrocytes encase capillar-
ies with their end feet and are therefore in a position to receive
unlabeled substrates from the blood, such as glutamine. Glu-
tamine appears to be transported through the blood–brain bar-
rier via the reversible systemN transporter that could facilitate its
bidirectional transport (Broer and Brookes, 2001). The high
plasma concentrations of glutamine (0.4–0.7 mM) (Kruse et al.,
1985) also make it a likely candidate for diluting the label.
The unique combination of two distinct tracers allowed the
validation of previous modeling assumptions used for 13C NMR
in the rat and human brain (Gruetter et al., 2001; Choi et al.,
2002). Namely, the present study reaffirmed the predominantly
neuronal localization of aspartate (Gundersen et al., 1998) (Fig.
1B) from both the low 14C-specific activity of aspartate and the
differential distribution of 13C in the C2 and C3 of glutamine
compared with aspartate.
In addition, the higher 14C-specific activity (Xu et al., 2004)
and the greater difference between C2 and C3 labeling of glu-
tamine relative to glutamate were consistent with a primarily glial
localization of anaplerosis. Interestingly, the C2–C3 difference in
glutamine was significantly higher than the difference in gluta-
mate only for the early time points, in agreement with a higher
contribution of pyruvate carboxylase compared with pyruvate
dehydrogenase to glutamine labeling earlier during the infusion
(Merle et al., 2002). Note that, if neuronal anaplerosis is present
(Hassel, 2001), the equilibration via fumarase backflux must be
complete in vivo, as in cultured neurons (Merle et al., 1996),
based on equal labeling of aspartate C2 and C3. In this case, our
glialVPCmeasurement would not be affected. However, substan-
tial neuronal anaplerosis would also contribute to the high degree
of 14C labeling in glutamate and would be inconsistent with the
relatively highVNTwe also found based solely on
13C data (Tables
2, 3).
Unaccounted label equilibration via fumarase backflux in glial
cells can cause underestimation of VPC (Table 2). In glial cell
cultures, this equilibration was reported to be 39% (Merle et al.,
1996). Furthermore, label was incorpo-
rated from H14CO3
 into lactate in the in-
tact retina (Lieth et al., 2001), implying
substantial fumarase backflux in vivo. The
fumarase backflux (Vfum), estimated from
the 13C and 14C data combined (Table 3,
bottom row), corresponds to 27% equili-
bration (Vfum/(Vfum  Vg)). After adding
Vfum to fitting the
13C data only (Table 3,
top row), 14C time courses very similar to
those obtained from the combined 13C
and 14C data were predicted (Fig. 4). Fur-
thermore, the fitting of 13C data alone
(without 14C data and Vfum) indeed un-
derestimated VPC (Table 2, top row), all
consistent with the presence of fumarase
backflux.
In the present model, we assumed that pyruvate carboxylase
activity leads to net citrate formation that is exported from the
glial compartment in the form of glutamine. However, the fixed
carbon may leave the TCA cycle also via phosphoenolpyruvate
carboxykinase or malic enzyme activity. Indeed, glial pyruvate
lactate is formed from TCA cycle intermediates inmodel systems
(Hassel and Sonnewald, 1995; Lieth et al., 2001). Incorporation
of such “pyruvate recycling” in the glial compartment of the
model led to a much higher rate of pyruvate carboxylase flux
(0.24 mol  gm1  min1 with 13C data only; 0.37
mol  gm1  min1 with 13C and 14C data combined), rein-
forcing that VPC obtained by the unmodified model represents
a lower limit.
Cerdan et al. (1990) observed neuronal pyruvate recycling in
the rat brain with [1,2-13C2]acetate (Cruz et al., 1998). When
using [1-13C]glucose, as in the present study, neuronal pyruvate
recycling would label the C5 position of glutamate, which could
be detected as a doublet at C4with a coupling constant of50Hz
(Henry et al., 2003b). However, even after addition of all spectra,
no labeling in this position above natural abundance was ob-
served, consistent with acetate being a better label precursor for
observing pyruvate recycling than glucose (Chapa et al., 2000).
Neuroglial metabolism in the awake rat brain
Glutamate–glutamine cycle
Comparedwith the neuronalmetabolic reactions, the glutamate–
glutamine cycle appears to be a significant flux in the awake rat
brain, because the differential labeling of the C2 and C3 of Glu
was not present in neuronal Asp and thuswas attributable to label
transfer from Gln. Differential labeling in C2 and C3 of Glu was
also observed in awake humans (Gruetter et al., 2001) and freely
moving rats (Aureli et al., 1997). Under anesthesia, Glu C2 and
C3 label equally after administration of [1-13C]glucose (Merle et
al., 2002; Henry et al., 2003a), consistent with a slower glutama-
te–glutamine cycle not able to transfer the unequal labeling pat-
tern from Gln to Glu.
Pyruvate carboxylase activity
The difference in 13C labeling of C2 andC3ofGln and substantial
labeling of amino acids from H14CO3
 clearly demonstrated the
presence of significant anaplerosis in the awake rat brain com-
pared with other reactions contributing to Gln labeling, such as
the glutamate–glutamine cycle and glial TCA cycle flux. Consis-
tently, anaplerosis comprises 25–35% of glutamine synthesis in
the human brain (Gruetter et al., 1998, 2001) and 19–26% of
glutamine synthesis in the-chloralose-anesthetized, normoam-
Figure 3. 13C-labeling time courses of C2, C3, and C4 of Glu, Gln, and Asp and best fit of themodel when fitted to both 13C and
14C data (see Fig. 1A,B). Error bars represent SEM.
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monemic rat brain (Sibson et al., 2001). A
high contribution of anaplerosis to glu-
tamine synthesis was also reported in the
rabbit (Lapidot and Gopher, 1994) and rat
brains (Aureli et al., 1997).
Comparison of neuroglial metabolism
in awake with deeply anesthetized brain
Comparedwith deep pentobarbital anesthe-
sia (Choi et al., 2002), flux via pyruvate
carboxylase in the awake rat brain was
approximately fourfold higher, and glu-
tamate–glutamine cycle rate was 14-fold
higher. [This comparison was made with
values in Table 2, top row, because themod-
eling by Choi et al. (2002) used only 13C
data. Note that a reanalysis of the previously
reported pentobarbital data (Choi et al., 2002) with the extended
model, including a glial dilution flux (Vex), did not change the pub-
lished rates significantly (data not shown).] Consistently, the total
glutamine synthesis rate in the rat brain under pentobarbital anes-
thesia (Sibson et al., 1998)was also severalfold lower thanVPC in the
awake rat brain. These rate increases reemphasize the Magistretti
hypothesis, which proposed astroglia as an active component of
neurotransmission (Pellerin andMagistretti, 1994).
The rate of oxidative glial ATP synthesis increased by 3
mol  gm1  min1 compared with pentobarbital anesthesia
and thus in excess of the increase in ATP synthesis required for
glutamate trafficking (2  
VNT 1 mol  gm
1  min1).
Therefore, we propose that glial oxidative ATP synthesis sustains
additional metabolic reactions in the astrocyte that are related to
overall brain activity and not only those that maintain glutama-
tergic action. Astrocytes appear far more involved in the regula-
tion of synaptic transmission than thought previously and pro-
vide an extensive network capable of ATP release and calcium
signaling, among others (Nedergaard et al., 2003; Newman,
2003).
Conventionally, anaplerosis is thought to provide a replenish-
ment of TCA cycle intermediates and is not associated with glu-
tamate neurotransmission. The current study suggests otherwise,
because a substantial increase of pyruvate carboxylase flux was
observed with increasing brain activity. Interestingly, the release
of potassium from activated neurons increases the influx of bi-
carbonate into astrocytes (Brookes and Turner, 1994), which in
turn may increase anaplerosis, as was reported in cultured astro-
cytes (Gamberino et al., 1997). Brookes and Turner (1993) also
observed an increase in intracellular glutamine concentration in
astrocytes as a result of raising the extracellular potassium con-
centration (Brookes, 2000). They concluded that this local rise in
concentration would cause glutamine to diffuse intracellularly
away from the active zone. Hence, glutaminemay be lost because
of diffusion, either intracellularly or extracellularly, resulting in a
nonstoichiometric exchange of glutamine and glutamate be-
tween the perisynaptic glial cell and the presynaptic neuron. Our
working hypothesis is that an increase of pyruvate carboxylase flux
with neurotransmissionmay be compensating for such a loss.
Note that, if the carbon backbone added to the TCA cycle via
anaplerotic synthesis is exported from the glial compartment in
the form of glutamine, fewer than six oxygen molecules are used
per molecule of glucose. Therefore, a transient increase in pyru-
vate carboxylase flux with increased brain activity may in part
explain the transient uncoupling between oxygen and glucose
utilization during neuronal activation (Mintun et al., 2002).
In conclusion, the present study reaffirms a mathematical
model described previously and its ability to determine a low
limit to glial pyruvate carboxylase flux when [1-13C]glucose is
used as precursor. We conclude that, in the awake rat brain,
pyruvate carboxylase flux is substantial and higher than under
conditions of depressed electrical activity, suggesting that anaple-
rosis is required for maintaining glutamatergic neurotransmis-
sion. Last, we conclude that glial oxidative ATP synthesis is sub-
stantial and most likely increases with brain activity.
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